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The relationship between neuronal impulse activity and neurotransmitter release remains elusive. This issue is especially poorly under-
stood in the neuroendocrine system, with its particular demands on periodically voluminous release of neurohormones at the interface
of axon terminals and vasculature. A shortage of techniqueswith sufficient temporal resolution has hindered real-timemonitoring of the
secretion of the peptides that dominate among the neurohormones. The lactotropic axis provides an important exception in neurochem-
ical identity, however, as pituitary prolactin secretion is primarily under monoaminergic control, via tuberoinfundibular dopamine
(TIDA) neurons projecting to the median eminence (ME). Here, we combined electrical or optogenetic stimulation and fast-scan cyclic
voltammetry to address dopamine release dynamics in the male mouse TIDA system. Imposing different discharge frequencies during
brief (3 s) stimulation of TIDA terminals in the ME revealed that dopamine output is maximal at 10 Hz, which was found to parallel the
TIDAneuron action potential frequency distributionduring phasic discharge. Overmore sustained stimulation periods (150 s),maximal
output occurred at 5 Hz, similar to the average action potential firing frequency of tonically active TIDA neurons. Application of the
dopamine transporter blocker, methylphenidate, significantly increased dopamine levels in the ME, supporting a functional role of the
transporter at the neurons’ terminals. Lastly, TIDA neuron stimulation at the cell body yielded perisomatic release of dopamine, which
may contribute to an ultrafast negative feedbackmechanism to constrain TIDA electrical activity. Together, these data shed light on how
spiking patterns in the neuroendocrine system translate to vesicular release toward the pituitary and identify how dopamine dynamics
are controlled in the TIDA system at different cellular compartments.
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Introduction
The relationship between neuronal impulse traffic and the
amount of transmitter released at the axonal terminal has en-
gaged neuroscience since the initial description of quantal release
(Del Castillo and Katz, 1954). A question triggered by these sem-
inal observations on the effects of a single action potential was
how different patterns and frequencies of discharge translate into
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Significance Statement
A central question in neuroscience is the complex relationship between neuronal discharge activity and transmitter release. By
combining optogenetic stimulation and voltammetry, we address this issue in dopamine neurons of the neuroendocrine system,
which facesparticular spatiotemporal demandsonexocytotic release; large amountsofneurohormoneneed tobe secreted into the
portal capillaries with precise timing to adapt to physiological requirements. Our data show that release is maximal around the
neurons’ default firing frequency.We further provide support for functional dopamine transport at the neurovascular terminals,
shedding light on a long-standing controversy about the existence of neuroendocrine transmitter reuptake. Finally, we show that
dopamine release occurs also at the somatodendritic level, providing a substrate for an ultrashort autoregulatory feedback loop.
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neurotransmitter exocytosis. The conversion from electrical (ac-
tion potential) to chemical (Ca2-dependent vesicle release and
subsequent receptor binding) identity of the neuronal signal in-
troduces several nonlinearities into the process, which compli-
cate the relationship between discharge pattern and secretion.
This issue has been addressed in the well-characterized dopami-
nergic substantia nigra and ventral tegmental area populations,
projecting to the caudate-putamen and nucleus accumbens, re-
spectively, revealing the frequency dependence of dopamine out-
put (L. Zhang et al., 2009; Bass et al., 2010). Thus, mesencephalic
dopamine terminals exhibit a preferred frequency for optimal
neurotransmitter output. Such a mechanism allows neurons to
recruit different vesicle and neurotransmitter pools (Iverfeldt et
al., 1989; Liu et al., 2011; Doussau et al., 2017), increasing the
computational capacity of individual cells. It also provides a
safety mechanism, as low activity often will not translate to sub-
stantial output (Ngodup et al., 2015).
The neuroendocrine system exhibits several features that dis-
tinguishes it from canonical CNS circuits. Instead of a postsyn-
aptic neuron, the targets of the parvocellular systems consist of
the endocrine cells of the anterior pituitary gland, which the re-
leasing and inhibiting factors of the neuroendocrine neurones
reach by way of the portal capillaries following release at the
neurovascular interface (Harris, 1948a,b). The demands on neu-
rohormone volume that follow from this structural organization
likely differ substantially from those required to elicit action
within the prototypical synapse. Furthermore, the secretion of
signal substances into the bloodstream rather than into a con-
fined synaptic cleft suggests that conditions for signal substance
reuptake, if it occurs at all, may be different. However, these
issues have been difficult to explore because of the lack of high-
resolution techniques in the temporal domain to quantitatively
measure release of neuropeptides and/or neurohormones (with
rare exceptions; Glanowska et al., 2012).
Among the hypothalamo-pituitary systems, the lactotropic
axis stands out, however, because of its inhibitory effect on target
cells and the monoaminergic nature of its chemical signal. Tu-
beroinfundibular dopamine (TIDA) neurons located in the
dorsomedial arcuate nucleus (dmArc) provide a powerful sup-
pressive influence on pituitary lactotrope cells, which produce
the hormone, prolactin (Lyons and Broberger, 2014; Grattan,
2015). Prolactin, in turn, plays an important role in, for example,
reproduction. A surge in circulating prolactin during late preg-
nancy and lactation triggers several important physiological
functions in the mother, including lactation and maternal care
(Grattan, 2015). Dopamine, released in the median eminence
(ME) for passage to the hypophyseal portal blood circulation,
tonically inhibits the lactotropes through dopamine D2-type re-
ceptors (Gudelsky, 1981; Malgaroli et al., 1987; Israel et al., 1990;
Lledo et al., 1990; Stefaneanu et al., 2000). Recent studies have
revealed distinguishing electrophysiological characteristics of
TIDA cells (Lyons et al., 2010), including the capacity for a vari-
able repertoire of firing frequencies in mouse neurons (Romano`
et al., 2013; Stagkourakis et al., 2018).
Dopamine release can be monitored with high temporal pre-
cision and chemical specificity through fast-scan cyclic voltam-
metry (FSCV) (Baur et al., 1988; Robinson et al., 2003; Rodeberg
et al., 2017). Here, we used electrical (Garris et al., 1997) and
optogenetic stimulation (Brimblecombe et al., 2015; Melchior et
al., 2015) to impose different discharge protocols upon mouse
TIDA neurons and recorded the resultant dopamine release at
different cellular compartments. The results provide evidence for
frequency optimization, functional reuptake through the dopa-
mine transporter (DAT) at TIDA terminals, and a recently pro-
posed ultrashort autoinhibitory feedback loop (Stagkourakis et
al., 2016).
Materials andMethods
Animals. All animal experiments had received approval from the local
ethical board, Stockholms Norra Djurfo¨rso¨ksetiska Na¨mnd, and were
performed in accordance with the European Communities Council Di-
rective of November 24, 1986 (86/609/EEC). WT mice with C57BL/6J
and BALB/c background were used, in addition to previously generated
C57BL/6J Slc6aCre (DAT-Cre) knock-in (Ekstrand et al., 2007) and
floxed-tdTomato mice (The Jackson Laboratory, strain datasheet
007909). Animals were group-housed, up to 5 per cage, in a temperature-
controlled (23°C) and humidity-controlled (55%) environment, in a
12/12 h light/ dark cycle with ad libitum access to food and water. Cages
were changed on a weekly basis.
Viral vectors. For channelrhodopsin in vitro optogenetic studies
animals were microinjected (see below) in the dmArc with 250 nl of
AAV5-EF1a-DIO-hChR2(H134R)-eYFP-WPRE-hGH (Addgene, 20298)
8.41 1012 genomic copies per milliliter. Control groups were injected
with 250 nl of AAV5-EF1a-DIO-eYFP-WPRE-hGH (Addgene, 27056)
5.82  1012 genomic copies per milliliter. The ChR2 and control eYFP
AAV5s were prepared by the University of Pennsylvania Vector Core.
Stereotactic surgery and viral gene transfer. Adult DAT-Cre male mice
of 3–6months age (sexually inexperienced)were stereotactically injected
with a virus (see below) and subsequently individually housed for 2
weeks after surgery. Animals were anesthetized with isoflurane (1%–5%)
and placed in a stereotaxic frame (David Kopf Instruments). Virus was
bilaterally injected into the dmArc using a pulled glass capillary (World
Precision Instruments) by nanoliter pressure injection at a flow rate of 50
nl per minute (Micro4 controller, World Precision Instruments; Nano-
jector II, Drummond Scientific). Stereotactic injection coordinates
(bregma: 1.8 mm, midline 0.1 mm, dorsal surface 5.5 mm) to
target the dmArc were obtained from the Paxinos and Franklin atlas
(Franklin and Paxinos, 2008). The rostrocaudal extent of viral infections
was confined to the dmArc, and transduced DAT positive neurons were
typically found between1.5mmand2.00mm frombregma, yielding
two useful brain slices per animal.
Brain slice electrophysiology. Acute slices of the mediobasal hypothala-
mus were prepared from adult DAT-tdTomatomice. Slices were cut on a
vibratome (LeicaMicrosystems VT1000S) to 250m thickness and con-
tinuously perfused with oxygenated aCSF containing the following (in
mM): 127 NaCl, 2.0 KCl, 1.2 NaH2PO4, 26 NaHCO3, 1.3 MgCl2, 2.4
CaCl2, and 10 D-glucose, at 32  1°C during recording. Each slice was
exposed only to a single bath application of pharmacological compounds
and was used for a single experiment. Whole-cell current- and voltage-
clamp recordings were performed with micropipettes filled with intra-
cellular solution containing the following (in mM), 140 K-gluconate, 10
KCl, 10HEPES, 10 EGTA, and 2Na2ATP, pH7.3, withKOH.Recordings
were performed using a Multiclamp 700B amplifier, a DigiData 1440
digitizer, and pClamp 10.2 software (Molecular Devices). Slow and fast
capacitative components were semiautomatically compensated. Access
resistance was monitored throughout the experiments, and neurons in
which the series resistance exceeded 15 M or changed 20% were ex-
cluded from further analysis. Liquid junction potential was 16.4 mV and
not compensated. The recorded current was sampled at 20 kHz.
For in vitro optogenetics during slice whole-cell recordings, photo-
stimulation was generated through a 3.4W 447 nmLEDmounted on the
microscope oculars and delivered through the objective lens. Photo-
stimulation was controlled via the analog outputs of a DigiData 1440A,
enabling control over the duration and intensity. The photostimulation
diameter through the objective lens was 350 m with illumination
intensity typically scaled to 3 mW/mm2. MATLAB (The MathWorks)
and OriginPro 8 (OriginLab) were used for electrophysiological data
analysis.
Immunofluorescence. Mice were anesthetized with sodium pentobar-
bital (200 mg/kg, i.p., Sanofi-Aventis), then transcardially perfused with
10 ml Ca2-free Tyrode’s solution (37°C) containing 0.2% heparin, fol-
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lowed by 10 ml fixative (4% PFA and 0.4% picric acid in 0.16 M PBS,
37°C), and then 50 ml ice-cold fixative. Whole brains were dissected,
immersed in ice-cold fixative for 90 min, and then stored in 0.1 M PBS,
pH 7.4, containing 20% sucrose, 0.02% bacitracin, and 0.01% sodium
azide for 3 d, before freezing with CO2. Coronal sections were cut at a
thickness of 14 m using a cryostat (Microm) and thaw-mounted onto
gelatin-coated glass slides. For indirect immunofluorescence staining
(performed at room temperature unless otherwise specified), air-dried
sectionswerewashed in 0.01 MPBS for 30min before incubationwith the
primary antibody diluted in PBS containing 0.3% Triton X-100 and 1%
BSA for 16 h at 4°C. The slides were then washed for 30 min in PBS
followed by 2 h incubation with Alexa-488-conjugated donkey anti-
rabbit secondary antisera (1:500; Invitrogen). Immunohistochemistry
for pSTAT5: Before immunofluorescence staining, antigen retrieval was
performed by incubating sections for 15 min in citric acid, pH 7.4, at
80°C, and then cooled at room temperature for a further 30 min. After a
1%H2O2 Tris-buffered wash, sections were incubated in rabbit pSTAT5
primary antibody (pSTAT5 Tyr 694, catalog #C11C5, 1:500; Cell Signal-
ing Technology) for 72 h at 4°C. Primary antibody incubation was fol-
lowed by Cy5-conjugated donkey anti-rabbit secondary antisera (1:500;
Invitrogen). TH immunoreactivity was detected via anti-TH antiserum
(1:2000; raised in rabbit, AB152, Millipore), and was followed by
Alexa488-conjugated goat raised anti-rabbit secondary antisera (1:
500; Invitrogen). Slides were incubated with the nuclear marker DAPI
(Invitrogen) diluted 1: 10,000 in PBS for 5 min before a final wash for
30 min in PBS, and mounted with glycerol containing (2.5%DABCO;
Sigma-Aldrich).
TIDA cell identification in C57 WT mice. TIDA neuron recordings
from C57 WT mice were performed in dmArc using intracellular solu-
tion containing 0.2% Neurobiotin. After recording, slices were placed in
fixative (4% PFA/0.16% picric acid), washed in PBS, and incubated at
4°C for 72 h in a solution containing FITC-conjugated avidin (1:2500,
43-4411, Zymed) and rabbit anti-TH immunoglobulin (1:2000, AB152,
Millipore). Followingwashing, slices were incubated in secondary Alexa-
594-conjugated donkey-anti-rabbit antiserum (1:500; Invitrogen;
A21202) for 24 h at 4°C, washed again, andmounted with 2.5%DABCO
in glycerol. Cells colocalizing FITC and TH in the dmArc were consid-
ered as TIDA neurons.
ISH. DAT-Cre-floxed-tdTomato mice were anesthetized with pento-
barbital, killed by decapitation, and the brains were rapidly removed and
frozen on dry ice; 10-m-thick coronal sections were cut using a cryostat
and thaw-mounted onto SuperFrost glass slides. Sections were fixed in
4% PFA for 15 min at 4°C and then dehydrated through incubation in
50% EtOH (1  5 min), 70% EtOH (1  5 min), and last 100% EtOH
(2 5 min). Slides were air-dried for 10 min, and a hydrophobic barrier
was created around each section using the ImmEdge pen (Vector Labo-
ratories). ISH was performed using a modification of the RNAScope
(Advanced Cell Diagnostics) protocol. Pretreat 4 (ACDBio, RNAscope
Fluorescent Multiplex Reagent Kit, 320850) was added to entirely cover
the sections for 30min at room temperature. After PBSwashing, sections
were incubated withMm-Th-C3 (317621-C3), Mm-Slc6a3-C2 (315441-
C2), and tdTomato (317041) RNAscope probes for 2 h at 40°C using the
HybEZ Humidifying System (ACDBio). The following incubation steps
were thenperformed:Amp1-FL for 30min at 40°C,Amp2-FL for 15min
at 40°C, Amp 3-FL for 30 min at 40°C, and Amp 4-FL-AltB for 15 min at
40°C (320850). Wash buffer (320850) was used to rinse the slides after
each step. Sections were incubated with DAPI solution (320850) for 30 s
at room temperature, and ProLong Gold Antifade Mountant (Thermo
Fisher Scientific) was added before placing the coverslips. Quantification
of mRNA coexistence within cells was performed on confocal Z-stack
dmArc images acquired at 40magnification.
Confocal microscopy. Brain slices were imaged by epifluorescence mi-
croscopy (Carl Zeiss, Imager M1) or confocal microscopy (Carl Zeiss,
LSM 800) for subsequent analysis. Brain areas were determined accord-
ing to their anatomy using Paxinos and Franklin brain atlas (Franklin
and Paxinos, 2008).
Carbon fiber microelectrodes. Carbon fiber electrodes were fabricated
by aspirating 7-m-diameter carbon fibers (Cytec EngineeredMaterials)
into borosilicate glass capillaries (1.2 mm O.D., 0.69 mm I.D., Sutter
Instrument). The capillaries were subsequently pulledwith a commercial
micropipette puller (Sutter Instrument, P-97) and sealed with epoxy
(EpoTek 301, Epoxy Technology). The electrode tips were polished at a
45° angle on a diamond dust-embedded micropipette-beveling wheel
(model BV-10, Sutter Instrument). Electrodes were tested in solutions of
known concentrations of dopamine. Only electrodes showing reaction
kinetics typical of dopamine (as examined in current vs time plots, and
current vs voltage plots) were used.
FSCV. A Chem-Clamp potentiostat (Dagan) and two data acquisition
boards (PCI-6221,National Instruments) run by the TH1.0CVprogram
(ESA) were used to collect all electrochemical data. Cyclic voltammo-
grams were obtained by applying a triangular waveform potential (0.4
to 1.3 V vs Ag/AgCl) repeated every 100 ms at a scan rate of 200 V/s (low
pass Bessel filter at 3 kHz). Each cyclic voltammogram was a
background-subtracted average of 10 successive cyclic voltammograms
taken at the maximum oxidation peak current. All electrodes were al-
lowed to cycle for at least 15 min before recording to stabilize the back-
ground current. The recorded current response was converted to
dopamine concentration via in vitro electrode calibration in a standard
dopamine solution after each experiment. Acquired data were analyzed
and plotted using MATLAB routines, and statistical analysis was per-
formed using Prism 6.0 (GraphPad). Last, bath application of the DAT
blocker methylphenidate in isolation (i.e., in the absence of a brain slice)
did not generate oxidative current during FSCV recordings (n  3).
Methylphenidate hydrochloride (M2892, Sigma-Aldrich) was dissolved
in aCSF and was bath applied via gravitational flow. TTX was purchased
from Alomone Labs (CAS #18660–81-6) and dissolved in deionized
H2O. 4-AP (275875) and cadmium chloride (CdCl2, 275875) were pur-
chased from Sigma-Aldrich, and were dissolved in deionized H2O.
Extracellular stimulation. Electrical stimulation of the external zone of
the lateral ME was performed with borosilicate glass microcapillaries
(same as used for patch recordings), connected to a stimulus isolation
unit (MI401; Zoological Institute, University of Cologne, Cologne, Ger-
many). The stimulation intensity was set to 2 the minimal stimulus
intensity required to reliably evoke dopamine release events using a stim-
ulation protocol of 3 s, 10 Hz, and 5 ms pulse width and typically scaled
between 10 and 100 mA in amplitude. Only WT C57BL/6J mice were
used on FSCV recordings with electrically evoked dopamine release.
Experimental design and statistical analysis. Immunohistochemistry
and in situ data were collected from a minimum of 8 animals, each
animal contributing a single or two sections per dataset. Electrophys-
iology data were collected from 10 animals, each animal contributing
four or five cells in the dataset. FSCV data were collected from mul-
tiple brain slices collected from aminimum of 3 individual animals on
consequent experimental days. A minimum of five recordings repre-
sent each FSCV data group. All t tests and one-way ANOVAs were
performed using Prism software (GraphPad). The appropriate post
hoc test was used for each one-way ANOVA. Normality was deter-
mined by D’Agostino-Pearson normality test. Statistical significance
was set at p 	 0.05.
Results
Absence of detectable spontaneous dopamine release in
coronal hypothalamic slices
TIDA neurons (Fig. 1A) were targeted for recording using DAT-
tdTomato mice (Fig. 1B–D). To evaluate the coexpression be-
tween TH and DAT, and the DAT-Cre mouse line as an
appropriate model for identifying TIDA cells, we performed
triple-label ISH for TH, DAT, and tdTomato in hypothalamic
brain sections fromDAT-tdTomatomice (Fig. 1E). Themajority
(84%) of cells expressed all three mRNA species, suggesting that
the DAT-Cre line offers a suitable model for investigation of
TIDA neuron physiology (i.e., dopaminergic neurons in the
dmArc; Fig. 1F).
Whole-cell patch-clamprecordings confirmed thatmouseTIDA
neurons exhibit a diverse range of firing rates in vitro in agreement
with earlier reports (Romano` et al., 2013; X. Zhang and van denPol,
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2015; Stagkourakis et al., 2018) (Figure 1G). The majority (71%) of
TIDA cells were found to have a tonic firing pattern with phasic
alterations in firing frequency, echoed in phasic fluctuations in
membrane voltage (Fig. 1G, middle). Approximately one-fourth of
the cells exhibited oscillatory, rhythmic firing interspersedwith brief
(500 ms) periods of quiescence (Fig. 1G, left). A small fraction of
the TIDA neurons in the slice preparation were consistently hyper-
polarized and quiescent (Fig. 1G, right).
As TIDA neurons are spontaneously active in vitro, we first
asked whether baseline dopamine release can be detected at the
site of the terminals in the slice preparation. Carbon fiber elec-
trodeswere thus placed in theME, and an adapted FSCVprotocol
from Kosillo et al. (2016) was applied (Fig. 1H). In this configu-
ration, no dopamine signal could be observed above the detec-
tion threshold (10 nM; N  20 recordings from N  10 slices
fromN 5 mice; Fig. 1I–K). One possible reason for this failure
to detect dopamine may be that the axons connecting the TIDA
cell somata in the dmArc and the terminals in the ME are largely
severed in the coronal slice preparation, as indicated by cyto-
architectonic studies (van den Pol and Cassidy, 1982), interrupt-
ing impulse traffic. Similar observations have occurred in other
dopamine systems, such as in the striatum (Threlfell et al., 2012;
O’Neill et al., 2017) and nucleus accumbens (Melchior and Jones,
2017), where the absence of spontaneous dopamine release in
slice preparations has motivated electrically or optically evoked
investigations of dopamine release dynamics at different condi-
tions. We therefore next sought to identify evoked dopamine release
propertiesviaoptogeneticstimulationoftheTIDAterminals.Thisstrat-
egy offers the benefit that the dynamics of the transmitter release at the
level of the terminals, on theonehand, andat the somatodendritic level
on the other, can be studied separately.
Stable electrically and optically evoked dopamine release in
the ME
To enable dopamine release from the terminals, we first used
extracellular electrical stimulation of the lateral part of the ME
during voltammetric recordings using brain slices from C57WT
mice (Fig. 2A). Electrical stimulation of the ME led to reliable,
stable dopamine release over time when tested with 5 min sam-
pling interval (Fig. 2B,E;N 5, F(2.258,9.034) 0.3811, df 6, p
0.7171, repeated-measures one-way ANOVA; Table 1). Next, to
study optogenetically evoked dopamine release, DAT-Cre ani-
mals were bilaterally injected in the dmArc with AAV-DIO-
ChR2-eYFP-hGH. One month later, FSCV recordings were
Figure 1. TIDA neuron preparation and absence of detectable spontaneous dopamine release in theME in acute hypothalamic slices.A, Schematic illustration of the lactotropic axis and the TIDA
neuron projection to theME.B–D, DAT promoter-driven expression of tdTomato for the identification of TIDA cells after fixation (B) and in acute brain slices used for electrophysiology visualized in
differential interference contrast (DIC) (C), and in fluorescence (D, converted to black andwhite and inverted) illumination, respectively. E, ISH for the TH, DAT, and tdTomatomRNA to quantify TH-,
DAT-, and Cre-mediated expression of floxed constructs in the DAT-Cremouse line (top). Highmagnification of three cells indicated via white arrows in E (bottom). F, Quantification of TH, DAT, and
tdTomatomRNA coexistence in cell bodies reveals an 84% colocalization between the three transcripts (N 16 confocal images collected from N 8 arcuate containing sections [1.8mm from
bregma] from8mice).G,Mouse TIDAneurons exhibit various patterns of activity, suprathreshold oscillations (left), subthreshold oscillations (middle), andquiescent behavior (right). Quantification
of theproportionof TIDAneurons exhibiting thedifferent formsof activity presented in the far right.H, Schematic drawing illustrating theuseof FSCVand carbon fiber (CF) disc electrodes tomeasure
TIDA neural activity with neurotransmitter (dopamine) release in the ME. I–K, Representative color plot (I ), current versus time plot (K ), and voltammogram (J ) generated through voltammetric
measurements revealing no spontaneous dopamine release above detection threshold (5–10 nM) in the ME (N 20 recordings from N 10 slices from N 5 mice). 3V, Third ventricle.
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performed in vitro to test for optically evoked dopamine release
(Fig. 2A,C). Using a stimulation protocol of 5 s in duration and
10 Hz frequency stimulation with 5 ms pulse width, robust and
stable dopamine release was recorded from the ME (Fig. 2D,E)
similarly to what was observedwith electrically evoked dopamine
measurements. To test for the possibility of dopamine depletion
at the terminals with repeated stimulation, we performed recur-
rent photostimulation at different time intervals (1 or 5 min).
Photostimulation with 5 min interval resulted in stable evoked
release at near 100% of the initial levels, throughout a 30 min
period (Fig. 2E;N 7, F(3.161,18.96) 0.2747, df 6, p 0.8522,
repeated-measures one-way ANOVA; Table 1), whereas photo-
stimulation with 1 min intervals resulted in attenuation of the
dopamine signal to near 50% of the basal levels over 10 min (Fig.
2F; N  5, F(3.036,12.14)  2.188, df  14, p  0.1413, repeated-
measures one-way ANOVA; Table 1). Once the longer (5 min)
photostimulation interval was reinstated, however, the dopa-
mine signal recovered to initial levels (Fig. 2F). Previouswork has
suggested that AAVs containing the hGH minigene can poten-
tially alter excitability of transduced endocrine cells (Brouwers et
al., 2014). Because the viral constructs used in the present study
contain the hGHminigene, control experiments were performed
to address whether this construct might influence TIDA behav-
ior. However, quantification of firing rates and pSTAT5 immu-
noreactivity (as a marker of prolactin receptor activation via
hGH) (Goffin and Kelly, 1997; Buteau et al., 1998) in C57 WT,
DAT-tdTomato, and DAT-Cre mice injected with AAV-DIO-
eYFP-hGH did not yield any changes related to hGH expression
(Fig. 3A–D; Table 1).
Importantly, optically evoked dopamine release was found to
be sensitive to application of TTX (500 nM), whereas coapplica-
tion of TTX (500 nM) and 4-AP (100 M) led to partial recovery
Figure2. Evokeddopamine release in theME is stable over time.A, Schematic drawing illustrating theuse of FSCVwith electrically andoptically evokeddopamine release in theME.B, Electrically
evoked dopamine release at t 0min and 30min after, in arcuate slices fromWTC57BL/6Jmice (dashed circle line/peak represents the electrical stimulation artifact or another oxidizing substance
released in the ME following the stimulus). C, Confocal Z-stack micrograph illustrating virally mediated ChR2-eYFP expression in the dmArc in the DAT-tdTomato mouse. The ChR2-eYFP and
DAT-tdTomato fluorescence in the ME. D, Optogenetically evoked dopamine release at t 0min and 30min later, in arcuate slices from DAT-Cre mice of C57BL/6J background. E, Both electrically
(red) andoptically evoked (blue) dopamine releasewith a5min stimulation interval is sustainable over time (N5–7per group, repeated-measures one-wayANOVA,p
 0.05; Table 1).F, Evoked
dopamine release with a 1min stimulation interval leads to a reversible dopamine depletion, reversible upon return to a 5min stimulation interval (N 5 per group, repeated-measures one-way
ANOVA, p	 0.0001). G, Representative FSCV traces with ChR2-evoked dopamine release in control conditions: versus in the presence of the Na channel blocker TTX, versus coapplication of TTX
and the K channel blocker 4-AP, and versus coapplication of TTX4-AP and the nonselective Ca 2 channel blocker CdCl2.H, Quantification of dopamine release in different conditions illustrated
in G (repeated-measures one-way ANOVA, p 0.0032; Table 1). **p	 0.01. Data are mean SEM. 3V, Third ventricle.
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Table 1. Statistics





with Dunnett’s multiple compari-
sons test
5 F(2.258,9.034) 0.3811 6 0.7171 0 min versus 5 min 0.8652 NS
0 min versus 10 min 
0.9999 NS
0 min versus 15 min 0.9961 NS
0 min versus 20 min 0.9891 NS
0 min versus 25 min 0.2479 NS





with Dunnett’s multiple compari-
sons test
7 F(3.161,18.96) 0.2747 6 0.8522 0 min versus 5 min 0.5051 NS
0 min versus 10 min 0.9983 NS
0 min versus 15 min 0.8838 NS
0 min versus 20 min 0.9983 NS
0 min versus 25 min 0.9960 NS
0 min versus 30 min 0.9968 NS
Figure 2F Repeated-measures one-way ANOVA
with Dunnett’s multiple compari-
sons test
5 F(3.036,12.14) 2.188 14 0.1413 0 min versus 1 min 
0.9999 NS
0 min versus 2 min 0.7617 NS
0 min versus 3 min 0.9999 NS
0 min versus 4 min 0.9156 NS
0 min versus 5 min 0.9098 NS
0 min versus 6 min 0.3838 NS
0 min versus 7 min 0.0835 NS
0 min versus 8 min 0.0256 *
0 min versus 9 min 0.0218 *
0 min versus 10 min 0.2914 NS
0 min versus 15 min 0.9977 NS
0 min versus 20 min 0.9725 NS
0 min versus 25 min 0.9941 NS
0 min versus 30 min 0.8931 NS
Figure 2H (10 ms
pulse duration)
one-way ANOVA with Dunnett’s
multiple comparisons test
4 F(3,9) 1.282 3 0.0032 Control versus TTX 0.0068 **
Control versus TTX 4-AP 0.0757 NS
Control versus TTX 4-AP
CdCl2
0.0092 **
Figure 3B one-way ANOVA with Dunnett’s
multiple comparisons test
8–12 F(2,25) 0.1192 2 0.8881 C57 wt - TH versus DAT-tdTo-
mato
0.9889 NS
C57 wt - TH versus DAT-eYFP 0.9050 NS
C57 wt–TH pSTAT5 versus
DAT-tdTomato pSTAT5
0.8697 NS
C57 wt–TH pSTAT5 versus
DAT-eYFP pSTAT5
0.7708 NS
Figure 3D One-way ANOVA with Dunnett’s
multiple comparisons test
10–33 F(2,52) 0.3014 2 0.7411 DAT-tdTomato versus C57 0.9312 NS
DAT-tdTomato versus DAT-eYFP 0.6881 NS
Figure 4D Two-tailed paired t test 6 4.357 5 0.0073 **
Figure 4B Ordinary one-way ANOVA with
Tukey’s multiple comparisons test
33 F(14,338) 17.08 14 	0.0001 1st versus 4th AP 	0.0001 ****
2nd versus 4th AP 	0.0001 ****
5th versus 10th AP 
0.9999 NS
10th versus 14th AP 0.0132 *
10th versus 15th AP 0.0117 *





with Dunnett’s multiple compari-
sons test
6 F(1.935,9.677) 100.6 6 	0.0001 2 Hz versus 5 Hz 
0.9999 NS
2 Hz versus 10 Hz 0.0364 *
2 Hz versus 20 Hz 	0.0001 ****
2 Hz versus 30 Hz 0.0001 ***
2 Hz versus 40 Hz 	0.0001 ****
2 Hz versus 50 Hz 	0.0001 ****




5 F(6,24) 100.4 6 	0.0001 2 Hz versus 5 Hz 
0.9999 NS
2 Hz versus 10 Hz 0.9932 NS
2 Hz versus 20 Hz 	0.0001 ****
2 Hz versus 30 Hz 	0.0001 ****
2 Hz versus 40 Hz 	0.0001 ****
2 Hz versus 50 Hz 	0.0001 ****




4 F(1.503,4.508) 72.97 6 0.0004 2 Hz versus 5 Hz 
0.9999 NS
2 Hz versus 10 Hz 
0.9999 NS
2 Hz versus 20 Hz 0.0595 NS
2 Hz versus 30 Hz 0.007 **
2 Hz versus 40 Hz 0.0016 **
2 Hz versus 50 Hz 0.0005 ***
(Table continues.)
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Table 1. Continued
Figures Test N F or t df p Multiple comparisons Adjusted p p summary





with Dunnett’s multiple compari-
sons test
9 F(1.135,10.68) 86.62 8 	0.0001 2 Hz versus 5 Hz 
0.9999 NS
2 Hz versus 10 Hz 
0.9999 NS
2 Hz versus 20 Hz 	0.0001 ****
2 Hz versus 30 Hz 	0.0001 ****
2 Hz versus 40 Hz 	0.0001 ****
2 Hz versus 50 Hz 	0.0001 ****





with Dunnett’s multiple compari-
sons test
6 F(1.111,8.889) 4.124 5 0.0706 2 Hz versus 5 Hz 0.268 NS
2 Hz versus 10 Hz 0.3002 NS
2 Hz versus 20 Hz 0.2444 NS
2 Hz versus 30 Hz 0.2637 NS
2 Hz versus 40 Hz 0.7629 NS
2 Hz versus 50 Hz 0.4558 NS




F(1.067,8.536) 5.221 5 0.0481 2 Hz versus 5 Hz 0.1586 NS
2 Hz versus 10 Hz 0.0442 *
2 Hz versus 20 Hz 0.0852 NS
2 Hz versus 30 Hz 0.8233 NS
2 Hz versus 40 Hz 0.5971 NS
2 Hz versus 50 Hz 0.4555 NS




F(6.00,48.00) 11.77 5 	0.0001 2 Hz versus 5 Hz 0.0509 NS
2 Hz versus 10 Hz 0.0002 ***
2 Hz versus 20 Hz 0.7353 NS
2 Hz versus 30 Hz 0.6001 NS
2 Hz versus 40 Hz 0.416 NS
2 Hz versus 50 Hz 0.2369 NS






with Dunnett’s multiple compari-
sons test
5 F(1.816,7.265) 18.98 4 0.0015 2 Hz versus 5 Hz 0.0907 NS
2 Hz versus 10 Hz 0.0108 *
2 Hz versus 20 Hz 0.0710 NS
2 Hz versus 30 Hz 0.4024 NS
2 Hz versus 40 Hz 0.8639 NS
2 Hz versus 50 Hz 0.9965 NS
Figure 5D Ordinary one-way ANOVA with
Tukey’s multiple comparisons test
5 F(6, 28) 5.92 6 0.0004 0.5 Hz versus 1 Hz 0.9922 NS
0.5 Hz versus 2 Hz 0.4408 NS
0.5 Hz versus 5 Hz 0.0016 **
0.5 Hz versus 10 Hz 0.9448 NS
0.5 Hz versus 20 Hz 
0.9999 NS
0.5 Hz versus 30 Hz 0.9973 NS
1 Hz versus 2 Hz 0.844 NS
1 Hz versus 5 Hz 0.0097 **
1 Hz versus 10 Hz 0.9999 NS
1 Hz versus 20 Hz 0.9979 NS
1 Hz versus 30 Hz 0.8659 NS
2 Hz versus 5 Hz 0.1787 NS
2 Hz versus 10 Hz 0.9559 NS
2 Hz versus 20 Hz 0.5291 NS
2 Hz versus 30 Hz 0.177 NS
5 Hz versus 10 Hz 0.0219 *
5 Hz versus 20 Hz 0.0024 **
5 Hz versus 30 Hz 0.0004 ***
10 Hz versus 20 Hz 0.9734 NS
10 Hz versus 30 Hz 0.6909 NS
20 Hz versus 30 Hz 0.9907 NS
Kruskal–Wallis statistic p Multiple comparisons Adjusted p p-summary
Figure 5E One-way Kruskal–Wallis ANOVA 7 22964 	0.0001 0.5 Hz versus 1 Hz 	0.0001 ****
0.5 Hz versus 2 Hz 	0.0001 ****
0.5 Hz versus 5 Hz 	0.0001 ****
0.5 Hz versus 10 Hz 	0.0001 ****
0.5 Hz versus 20 Hz 	0.0001 ****
0.5 Hz versus 30 Hz 	0.0001 ****
1 Hz versus 2 Hz 
0.9999 NS
1 Hz versus 5 Hz 	0.0001 ****
1 Hz versus 10 Hz 	0.0001 ****
1 Hz versus 20 Hz 	0.0001 ****
1 Hz versus 30 Hz 	0.0001 ****
(Table continues.)
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Figure 3. Expression of the hGHminigene does not impact on TIDA neuron excitability. A, pSTAT5 immunoreactivity illustrated via confocal Z-stack micrographs at low (10) and high
(63) magnification in the dmArc of C57 WT (wt), DAT-tdTomato, and DAT-Cre mice injected with an hGH minigene-containing viral construct. B, Quantification of dopamine neurons
per hemisphere/section (box plots in green and white, N 8 –12 per group, one-way ANOVA, p 0.8881; Table 1), and dopamine neurons colocalizing with pSTAT5 (box plots in yellow,
N 8 –12 per group, one-way ANOVA, p 0.8059; Table 1). C, Representative traces of TIDA neuron firing patterns collected from C57 wt, DAT-tdTomato, and DAT-eYFP mice. D,
Quantification of TIDA neuron firing frequency, recorded from the different mouse lines (N 10 –33 per group, one-way ANOVA, p 0.7411; Table 1). Data are mean SEM. 3V, Third
ventricle.
Table 1. Continued
Figures Test N F or t df p Multiple comparisons Adjusted p p summary













Figure 6B Two-tailed paired t test 6 4.439 5 0.0068 **
Figure 6C Two-tailed paired t test 6 0.4974 5 0.6400 NS
Figure 6D Two-tailed paired t test 6 5.228 5 0.0034 **
Figure 6E Two-tailed paired t test 6 1.115 5 0.3154 NS
*p	 0.05; **p	 0.01; ***p	 0.001; ****p	 0.0001.
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(Fig. 2G,H; Table 1). Finally, coapplication of CdCl2 (400 M)
abolished the release of dopamine (Fig. 4G,H; Table 1). Together,
these data suggest that dopamine release in the tuberoinfundibu-
lar pathway is both action potential- and Ca2-dependent and
thus relies on similar mechanisms as in other systems.
Frequency preference for maximal dopamine release at the
level of the terminals matches the endogenous average firing
frequency of TIDA neurons
The majority of action potentials in the UP states of spontane-
ously active TIDA neurons (Fig. 4A) are discharged within a10
Figure 4. TIDA neuron endogenous firing frequency and optimal dopamine release in the ME terminals occur at 10 Hz. A, Whole-cell recording from a DAT-tdTomato neuron, with one UP state
shown in expanded temporal resolution (gray box below; action potentials [AP] truncated for clarity).B, Quantification of the instantaneous firing frequency (IFF) of AP in an UP state (N 33 cells,
one-way ANOVA, p	 0.0001; Table 1). C, Frequency distribution of IFF shows that the majority of spikes are discharged at 10 Hz. D, ChR2 current at the peak and steady state, mediated via 1 s
photostimulation (N 6, two-tailed paired t test, p 0.0073; Table 1). E, Representative traces with electrical square pulses and ChR2-driven AP firing at 10 and 50 Hz. The depolarization block
and low fidelity are at 50Hz. F, Quantification of spike fidelity versus photostimulation frequency and pulsewidth (repeated-measures one-wayANOVA; Table 1).G, Representative FSCV traceswith
electrically and ChR2-evoked dopamine release in theME at 10 and 50 Hz.H, Quantification of dopamine release in theME versus photostimulation frequency and pulse width (repeated-measures
one-way ANOVA; Table 1). *p	 0.05, **p	 0.01, ***p	 0.001, ****p	 0.0001. Data are mean SEM.
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Hz frequency (Fig. 4B; N  33, F(14,338)  17.08, df  14, p 	
0.0001, one-way ANOVA with Tukey’s test; Table 1), and the
instantaneous frequency follows a normal-like distribution with
a peak at 10.02 Hz (Fig. 4A,C). Following the characterization of
the ChR2-mediated current with a fast and a slow component
(Fig. 4D; N 6, t 4.357, df 5, p 0.0073, two-tailed paired
t test; Table 1) in somatic recordings, we investigated the spike
fidelity of the TIDA cells at different electrically and optically
evoked stimulation frequencies. Electrical or optogenetic stimu-
lation of DAT-Cre neurons at frequencies of 10 Hz yielded a
100% spike fidelity (Fig. 4E, top, F; Table 1), whereas higher
photostimulation frequencies (30–50Hz) led to a depolarization
block phase with substantial spike failure (Fig. 4E, bottom, F;
Table 1). The latter phenomenon has previously been described
in rat TIDA cells in response to pharmacological manipulations
(Stagkourakis et al., 2016).
Based on the observation that spontaneous TIDA discharge is
strongly biased to the 10 Hz frequency band, we next addressed
whether transmitter release at the TIDA terminals responds dif-
ferentially at different stimulation frequencies. To investigate this
issue, a brief (3 s) electrical or optical stimulation protocol was
applied at frequencies ranging from 2 to 50 Hz. Electrically
evoked dopamine release was investigated in WT mice of
C57BL/6J background, whereas optically evoked dopaminemea-
surementswere performed inChR2 transducedDAT-Cremice of
the C57BL/6J background. Maximal dopamine release was re-
corded at 10 Hz using both methods of stimulation, with both
higher and lower frequencies eliciting less dopamine signal
(Fig. 4G,H ). Importantly, the 10 Hz frequency yielded optimal
dopamine release regardless of pulse duration when using a
photostimulation protocol (Fig. 4H; Table 1). Together, these
data suggest that the membrane properties of TIDA neurons,
at the somatodendritic and axon terminal levels, are optimized
to both discharge and release neurotransmitter content at 10
Hz.
As dopamine release dynamics may vary between short and
long bouts of activity, we repeated the analysis of the frequency
and pulse duration dependence of dopamine release using a
longer-duration (150 s) photostimulation protocol. The maxi-
mal dopamine release signal was also here biased toward the
slower frequencies, with the greatest value recorded at 5 Hz (Fig.
5A–E; Table 1). Interestingly, the average firing frequency of su-
prathreshold oscillating TIDA neurons recorded in vitro is de-
tected in that range (Fig. 3C,D).
Figure 5. In tonic firing configuration, TIDA terminals release maximal amounts of dopamine in the ME at 5 Hz. A–C, Representative FSCV traces and heat maps with ChR2-evoked dopamine
release in the ME at 2, 5, and 20 Hz. D, Quantification of dopamine release in the ME versus photostimulation frequency with 5 ms pulse width (N 5, repeated-measures one-way ANOVA, p
0.0004; Table 1).E, Relative frequencyof dopamine releaseper second in theMEversus photostimulation frequencywith5mspulsewidth. *p	 0.05, **p	 0.01, ***p	 0.001, ****p	 0.0001.
Data are mean SEM.
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Functional DAT in the ME
The expression of DAT in TIDA neurons is well documented
(Meister and Elde, 1993; Revay et al., 1996; Demaria et al., 2000;
Stagkourakis et al., 2018), yet the functional role of the trans-
porter within the lactotropic axis remains controversial (Demar-
est and Moore, 1979; Annunziato et al., 1980; Meister and Elde,
1993; Revay et al., 1996; Bosse´ et al., 1997; Demaria et al., 2000;
Stagkourakis et al., 2018). To assess whether reuptake is involved
at determining dopamine levels at the entry to the portal vascu-
lature, we performed optogenetic stimulation of TIDA terminals
in theME, in the absence and presence of the clinically prescribed
DAT blocker, methylphenidate (Taylor and Ho, 1978; Volkow et
al., 1999a, b). Following application of methylphenidate (10 M;
Fig. 6A), the photostimulation-induced dopamine signal was
augmented, quantified as prolonged decay (Fig. 6B; N  6, t 
4.439, df 5, p 0.0068, two-tailed paired t test) and half-width
(Fig. 6D; N 6, t 5.228, df 5, p 0.0034, two-tailed paired
t test), whereas maximal [dopamine] release and rise time were
not affected (Fig. 6C,D; Table 1). These data suggest the presence
of functional dopamine transport active in the ME.
Capacity for dopamine release at the somatodendritic
compartment of TIDA neurons
Recent work has suggested that local release of dopamine around
the cell body and dendrites of TIDA neurons may serve as a
critical component of an ultrashort feedback loop that tunes the
electrical activity of these neurons to their recent transmitter se-
cretion history (Belousov and van den Pol, 1997; Durham et al.,
1998; Liang and Pan, 2012; Liang et al., 2014; Stagkourakis et al.,
2016). Yet to date, no direct evidence exists that dopamine can
indeed be released in the somatodendritic compartment in the
dmArc. To investigate this possibility, TIDA cells were trans-
duced with ChR2-eYFP. Inspection of cryostat sections of the
dmArc of such animals revealed that the ChR2 construct was
distributed on both cell bodies and dendrites of DAT-tdTomato-
positive neurons (Fig. 7A). We next performed FSCV recordings
in the dmArc with the carbon fiber electrode placed in the area
occupied by TIDA cell somata (Fig. 7B). As in the ME, no spon-
taneous release could be recorded. When photostimulation was
performed using the 5 s duration/10 Hz/5 ms pulse protocol
found to evoke optimal release in the ME (Fig. 4H ), however,
a distinct dopamine signal could be recorded (Fig. 7C,D). This
signal was typically 10- to 20-fold below that recorded in theME
(compare Fig. 7D and Fig. 4H). A photostimulation artifact is
evident at 0 and 1.3 V in the voltammogram, similar to what
has been described previously (Bass et al., 2013). These results
provide strong evidence for a capacity for
dopamine release at the cell body level of
TIDA neurons.
Discussion
The ability of a neuron to translate electrical
activity to chemical signal is a core feature of
the nervous system. Studies of dopamine
transmission in the basal ganglia (Oleson et
al., 2009; L. Zhang et al., 2009; Bass et al.,
2010; Sulzer et al., 2016) have identified sev-
eral principles of stimulus-secretion cou-
pling. Yet, the specific volume and coding
mechanisms of release used by different
brain systems are likely to vary depending
on their role in behavior and physiology.
Hereweaddressed this issue in theneuroen-
docrine tuberoinfundibular system, where
transmitter release from TIDA neurons can be monitored by FSCV
while TIDA spiking patterns can be controlled by optogenetic
stimulation.
We show that, while mouse TIDA neurons are able to spike
across a spectrum of frequencies, in agreement with previous
studies (Romano` et al., 2013, X. Zhang and van den Pol, 2015;
Stagkourakis et al., 2018), action potentials are primarily dis-
charged within a 10 Hz frequency band. When depolarized with
greater stimulation than required to reach this frequency, TIDA
neurons are successively more prone to depolarization block and
spike failure (Stagkourakis et al., 2016; and present data). Impor-
tantly,maximal dopamine release was accomplishedwith a 10Hz
stimulation frequency (concomitant with full spike fidelity) and
was abolished by the Na channel blocker TTX. Partial recovery
was achieved via coapplication of TTX and the potassium chan-
nel blocker 4-AP (Petreanu et al., 2009), whereas coapplication of
TTX, 4-AP, and the generic Ca2 channel blocker CdCl2 (Swan-
dulla and Armstrong, 1989) abolished dopamine release at the
TIDA terminals, suggesting that the dopamine thus recorded is
the result of an action potential- and Ca2-dependent process.
Thus, the system appears to be operating at full capacity at its
default spike rate (although it should be borne in mind that in
vivo discharge frequencies, currently not known for the TIDA
system, may be different). These results were recorded with 3 s
stimulation bouts, in the range of the typical TIDA oscillationUP
state in subthreshold oscillating cells (Stagkourakis et al., 2018).
For extended periods (150 s) of stimulation, the optimal fre-
quency was shifted toward slower frequencies. In the context of
these findings, it can be noted that sustained (tonic) firing is
triggered in TIDA neurons by modulators associated with inhi-
bition of prolactin release upon central administration (Lyons et
al., 2010; Briffaud et al., 2015). The firing frequency during this
transmitter/hormone-induced persistent discharge can be lower
than in the oscillatory state (Lyons et al., 2010), which may then
offer an adaptation to the extended firing/lower frequency prin-
ciple for optimal transmitter release suggested by the present
data.
The dopamine concentration elicited by optogenetic stimula-
tion ranged within 0.5–1.5 M, comparable with the levels
found in striatal recordings of dopamine release (Sulzer et al.,
2016). The comparison between brain regions is fraught with
complications, but it may be speculated that the dopamine con-
centrations evoked in theME are likely diluted in the portal blood
before reaching the target (lactotroph cells in the pituitary), un-
like striatal dopamine concentrations, which potentially act di-
Figure 6. Dopamine release dynamics in the ME change upon DAT blockade. A, Representative dopamine-evoked oxidative
current on baseline (green) and during (purple) DAT blockade with methylphenidate. B–E, Quantification of dopamine reuptake
parameters, such as decay (B), maximal amplitude of dopamine release (C), half-width (D), and rise time (E) (N 6, two-tailed
paired t test; Table 1). *p	 0.05, **p	 0.01, ***p	 0.001, ****p	 0.0001. Data are mean SEM.
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rectly on the postsynaptic cells (Ross, 1991; Korchounov et al.,
2010). But an additional possibility could be that excess dopa-
mine is necessary to compensate for the relatively less precise
delivery of dopamine across the neurovascular interface and cap-
illary distribution system compared with the point-to-point syn-
aptic transmission in the striatum. It can also be noted that the
levels we recorded are several magnitudes above those required
for activation of D2R autoreceptors (Gonon and Buda, 1985),
which may be present on the somatodendritic compartments or
TIDA terminals (Berry and Gudelsky, 1991; Huang et al., 2013;
Stagkourakis et al., 2016).
Previous in vitro (Romano` et al., 2013) and in vivo (Romano` et
al., 2017) amperometry investigations have indicated that in-
creased firing (induced by prolactin administration) in the TIDA
ensemble correlates to higher amperometric signal at the termi-
nal level, and that a range of release even frequencies can be
detected in the ME in the intact animal. Yet, a comprehensive
understanding of the coupling between TIDA neuron activity
and dopamine release at the terminals has been lacking. The
superior ability of FSCV over amperometry to identify trans-
mitters with chemical selectivity (Bucher and Wightman,
2015), combined with the millisecond precision control spik-
ing through optogenetics, has allowed us in the current study
to correlate specific firing patterns to dopamine release vol-
umes in the TIDA system, without contamination of other
transmitters and metabolites.
The role of DAT in TIDA neurons has been a subject of con-
troversy. Pharmacological studies of dopamine accumulation
initially suggested that dopamine reuptake had a minor effect on
ME levels, leading to conclusions that a transporter system was
not reconcilable with vascular release (Demarest and Moore,
1979; Annunziato et al., 1980). This conclusion has, however,
been challenged by subsequent studies using other DAT antago-
nists (Demaria et al., 2000) and genetic deletion (Bosse´ et al.,
1997). Indeed, a functional role for DAT in TIDA terminals re-
ceived early support from the demonstration that the dopamine
metabolite, 3,4-dihydroxyphenylacetic acid, likely the result of
metabolism following reuptake, is a well-correlated surrogate
marker for dopamine in theME (Lookingland et al., 1987). Here,
we show that optogenetically elicited dopamine release at theME
is powerfully amplified in the presence of methylphenidate, a
clinically used antagonist of DAT. It is important to remember in
this context that neuroendocrine neurons do not make immedi-
ate contact with portal capillaries, but rather abut a perivascular
space (Ajika and Ho¨kfelt, 1973) where release is postulated to
occur. This organization suggests that secreted dopamine may
linger for a period in the proximity of the terminal before ending
up in the bloodstream, allowing for a window of opportunity for
transmitter reuptake.
Recently, we have proposed the existence of an ultrashort
D2R-mediated feedback loop (Stagkourakis et al., 2016). This
model is primarily based on pharmacological and electrophysio-
logical findings, but a key component of this scheme is the exis-
tence of release of ambient dopamine at the somatodendritic
compartment, for which evidence has been lacking. The present
study shows that release of dopamine can be triggered at the cell
body level through optogenetic stimulation. Notably, the levels
thus elicited were approximately a magnitude lower than what
was recorded in the ME with similar stimulation. Our model
proposes that local dmArc releasemirrors fluctuations at theME,
but need not do so at similar absolute concentrations. Thus, the
current findings support the existence of an autoinhibitory feed-
back loop. The exact release site for this evoked dopamine
remains to be determined. Ultrastructural studies have demon-
strated that TIDA neurons extend recurrent collaterals that proj-
ect toward, but do notmake direct contact with, TIDA cell bodies
(Piotte et al., 1985), which could be providing extrasynaptic do-
pamine. There are, however, also dense dendrodendritic and so-
matodendritic contacts within the TIDApopulation (Piotte et al.,
1985). In the midbrain, such contacts have been implicated in
local release from the soma and/or dendrites (Hefti and Lichten-
steiger, 1978; Cheramy et al., 1981; Rice and Patel, 2015). The
current findings suggest that this possibility merits further inves-
tigation in the TIDA system.
In conclusion, the present data showhowdopamine dynamics
in the TIDA system correlate to spike rates, and identify regula-
tory mechanisms involved in this process at both the terminal
and somatodendritic level. These findings offer insight into the
relationship between electrical activity and signal substance re-
lease in the neuroendocrine system, and provide a platform for
further investigations of stimulus-secretion coupling in the
hypothalamo-pituitary axis.
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